Journal of managed care & specialty pharmacy Journal

Overview
Identity
View All

publication venue for

Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021.. 31:1207-1216. 2025
Associations of oseltamivir with neuropsychiatric and behavioral adverse events: A systematic review and meta-analysis.. 31:1051-1061. 2025
Addressing complexity: The development and pilot testing of a user-friendly Medicare Part D patient decision aid tool.. 31:868-878. 2025
The effectiveness and value of sonpiretigene isteparvovec for the treatment of advanced retinitis pigmentosa.. 31:835-840. 2025
Receipt of Medicare Part D comprehensive medication reviews in older adults with dementia.. 31:296-305. 2025
Dynamic changes in medication burden leading to fall and hospital readmissions in older adults: Toward a strategy for improving risk and managing costs.. 31:96-100. 2025
Journal of Managed Care. 30:736-746. 2024
Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.. 30:549-559. 2024
Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria.. 30:618-623. 2024
Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.. 30:609-616. 2024
A primer on brand-name prescription drug reimbursement in the United States.. 30:99-106. 2024
Impact of medication therapy management programs on potentially inappropriate medication use in older adults: A systematic review.. 30:3-14. 2024
Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis.. 29:1045-1053. 2023
Self-reported adherence and reasons for nonadherence among patients with low proportion of days covered for antihypertension medications.. 29:557-563. 2023
Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.. 29:266-275. 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.. 29:216-221. 2023
Health care utilization and expenditures of parents of children with and without hemophilia A.. 28:529-537. 2022
Trend and effects of high-deductible health insurance plans in the health care system: financial access problems in management of cognitive impairment.. 28:7-15. 2022
Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018.. 27:1332-1340. 2021
Validation of EHR medication fill data obtained through electronic linkage with pharmacies.. 27:1482-1487. 2021
Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.. 27:971-981. 2021
Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy.. 27:1142-1152. 2021
Impact of financial medication assistance on medication adherence: a systematic review.. 27:924-935. 2021
Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes.. 27:696-705. 2021
Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.. 26:1558-1566. 2020
Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.. 26:1582-1588. 2020
Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare's reimbursement policy.. 26:1477-1486. 2020
One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.. 26:520-528. 2020
Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017.. 26:562-567. 2020
Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission.. 26:296-304. 2020
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.. 26:169-175. 2020
Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.. 25:1201-1217. 2019
Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.. 25:342-349. 2019
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.. 24:1210-1217. 2018
Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.. 24:1230-1238. 2018
Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers.. 24:1173-1183. 2018
Effects of the 2009 USPSTF Depression Screening Recommendation on Diagnosing and Treating Mental Health Conditions in Older Adults: A Difference-in-Differences Analysis.. 24:769-776. 2018
Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.. 24:478-486. 2018
The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.. 23:1066-1076. 2017
Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States.. 23:653-664. 2017
Estimating Generic Drug Use with Electronic Health Records Data from a Health Care Delivery System: Implications for Quality Improvement and Research.. 22:1143-7. 2016
Using Certification to Promote Uptake of Real-World Evidence by Payers.. 22:191-6. 2016
Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department.. 22:74-80. 2016
Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.. 22:114-20. 2015
Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation.. 21:1054-62. 2015
Treatment Patterns of Anti-Vascular Endothelial Growth Factor and Laser Therapy Among Patients with Diabetic Macular Edema.. 21:735-41. 2015